Long-term follow up after denosumab treatment for osteoporosis – rebound associated with hypercalcemia, parathyroid hyperplasia, severe bone mineral density loss, and multiple fractures: a case report

BACKGROUND: The rebound effect after stopping treatment with denosumab may be associated with rapid loss of the gains in bone mineral density achieved with treatment, high levels of bone remodeling markers, the occurrence of vertebral fractures, and even hypercalcemia. CASE PRESENTATION: A 64-year-o...

Descripción completa

Detalles Bibliográficos
Autores principales: Maugars, Yves, Guillot, Pascale, Glémarec, Joëlle, Berthelot, Jean-Marie, Le Goff, Benoit, Darrieutort-Laffite, Christelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427054/
https://www.ncbi.nlm.nih.gov/pubmed/32792004
http://dx.doi.org/10.1186/s13256-020-02401-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427054/
https://www.ncbi.nlm.nih.gov/pubmed/32792004
http://dx.doi.org/10.1186/s13256-020-02401-0

Ejemplares similares